Antidepressant-like effects of κ-opioid receptor antagonists in the forced swim test in rats

Stephen D. Mague, Andrea M. Pliakas, Mark S. Todtenkopf, Hilarie C. Tomasiewicz, Yan Zhang, William C. Stevens, Robert M. Jones, Philip S. Portoghese, William A. Carlezon

Research output: Contribution to journalArticle

347 Citations (Scopus)

Abstract

We showed previously that cAMP response element-binding protein (CREB) within the nucleus accumbens (NAc) of rats regulates immobility in the forced swim test (FST), an assay used to study depression. Because CREB regulates expression of dynorphin (which acts at κ-opioid receptors) in NAc neurons, these findings raised the possibility that κ-receptors mediate immobility behaviors in the FST. Here, we report that i.c.v. administration of the κ-antagonist nor-binaltorphimine dose dependently decreased immobility in the FST, suggesting that it has antidepressant-like effects. Implicating a specific effect at κ-receptors, similar antidepressant-like effects were seen after treatment with either of two novel, structurally dissimilar κ-antagonists: 5′-guanidinonaltrindole, which was effective after i.c.v. but not systemic treatment, and 5′-acetamidinoethylnaltrindole (ANTI), which was potent and effective after systemic treatment. The behavioral effects of the κ-antagonists resembled those of tricyclic antidepressants (desipramine) and selective serotonin reuptake inhibitors (fluoxetine and citalopram). Conversely, systemic administration of the κ-agonist [5α,7α,8β]-N-methyl-N-[7-[1-pyrrolidinyl] -1-oxaspiro[4.5]dec8-yl]-benzenacetamide (U-69593) dose dependently increased immobility in the FST, consistent with prodepressant-like effects. The effects of the κ-ligands in the FST were not correlated with nonspecific effects on locomotor activity. Furthermore, the most potent and effective κ-antagonist (ANTI) did not affect the rewarding impact of lateral hypothalamic brain stimulation at a dose with strong antidepressant-like effects. These findings are consistent with the hypothesis that CREB-mediated induction of dynorphin in the NAc "triggers" immobility behavior in the FST. Furthermore, they raise the possibility that κ-antagonists may have efficacy as antidepressants, but lack stimulant or rewardrelated effects.

Original languageEnglish (US)
Pages (from-to)323-330
Number of pages8
JournalJournal of Pharmacology and Experimental Therapeutics
Volume305
Issue number1
DOIs
StatePublished - Apr 1 2003

Fingerprint

Narcotic Antagonists
Cyclic AMP Response Element-Binding Protein
Antidepressive Agents
Nucleus Accumbens
Dynorphins
Citalopram
Desipramine
Tricyclic Antidepressive Agents
Fluoxetine
Serotonin Uptake Inhibitors
Opioid Receptors
Locomotion
Depression
Ligands
Neurons
Brain

Cite this

Mague, S. D., Pliakas, A. M., Todtenkopf, M. S., Tomasiewicz, H. C., Zhang, Y., Stevens, W. C., ... Carlezon, W. A. (2003). Antidepressant-like effects of κ-opioid receptor antagonists in the forced swim test in rats. Journal of Pharmacology and Experimental Therapeutics, 305(1), 323-330. https://doi.org/10.1124/jpet.102.046433

Antidepressant-like effects of κ-opioid receptor antagonists in the forced swim test in rats. / Mague, Stephen D.; Pliakas, Andrea M.; Todtenkopf, Mark S.; Tomasiewicz, Hilarie C.; Zhang, Yan; Stevens, William C.; Jones, Robert M.; Portoghese, Philip S.; Carlezon, William A.

In: Journal of Pharmacology and Experimental Therapeutics, Vol. 305, No. 1, 01.04.2003, p. 323-330.

Research output: Contribution to journalArticle

Mague, SD, Pliakas, AM, Todtenkopf, MS, Tomasiewicz, HC, Zhang, Y, Stevens, WC, Jones, RM, Portoghese, PS & Carlezon, WA 2003, 'Antidepressant-like effects of κ-opioid receptor antagonists in the forced swim test in rats', Journal of Pharmacology and Experimental Therapeutics, vol. 305, no. 1, pp. 323-330. https://doi.org/10.1124/jpet.102.046433
Mague, Stephen D. ; Pliakas, Andrea M. ; Todtenkopf, Mark S. ; Tomasiewicz, Hilarie C. ; Zhang, Yan ; Stevens, William C. ; Jones, Robert M. ; Portoghese, Philip S. ; Carlezon, William A. / Antidepressant-like effects of κ-opioid receptor antagonists in the forced swim test in rats. In: Journal of Pharmacology and Experimental Therapeutics. 2003 ; Vol. 305, No. 1. pp. 323-330.
@article{d9fab7a1342b46e5932fecfe3d571e7a,
title = "Antidepressant-like effects of κ-opioid receptor antagonists in the forced swim test in rats",
abstract = "We showed previously that cAMP response element-binding protein (CREB) within the nucleus accumbens (NAc) of rats regulates immobility in the forced swim test (FST), an assay used to study depression. Because CREB regulates expression of dynorphin (which acts at κ-opioid receptors) in NAc neurons, these findings raised the possibility that κ-receptors mediate immobility behaviors in the FST. Here, we report that i.c.v. administration of the κ-antagonist nor-binaltorphimine dose dependently decreased immobility in the FST, suggesting that it has antidepressant-like effects. Implicating a specific effect at κ-receptors, similar antidepressant-like effects were seen after treatment with either of two novel, structurally dissimilar κ-antagonists: 5′-guanidinonaltrindole, which was effective after i.c.v. but not systemic treatment, and 5′-acetamidinoethylnaltrindole (ANTI), which was potent and effective after systemic treatment. The behavioral effects of the κ-antagonists resembled those of tricyclic antidepressants (desipramine) and selective serotonin reuptake inhibitors (fluoxetine and citalopram). Conversely, systemic administration of the κ-agonist [5α,7α,8β]-N-methyl-N-[7-[1-pyrrolidinyl] -1-oxaspiro[4.5]dec8-yl]-benzenacetamide (U-69593) dose dependently increased immobility in the FST, consistent with prodepressant-like effects. The effects of the κ-ligands in the FST were not correlated with nonspecific effects on locomotor activity. Furthermore, the most potent and effective κ-antagonist (ANTI) did not affect the rewarding impact of lateral hypothalamic brain stimulation at a dose with strong antidepressant-like effects. These findings are consistent with the hypothesis that CREB-mediated induction of dynorphin in the NAc {"}triggers{"} immobility behavior in the FST. Furthermore, they raise the possibility that κ-antagonists may have efficacy as antidepressants, but lack stimulant or rewardrelated effects.",
author = "Mague, {Stephen D.} and Pliakas, {Andrea M.} and Todtenkopf, {Mark S.} and Tomasiewicz, {Hilarie C.} and Yan Zhang and Stevens, {William C.} and Jones, {Robert M.} and Portoghese, {Philip S.} and Carlezon, {William A.}",
year = "2003",
month = "4",
day = "1",
doi = "10.1124/jpet.102.046433",
language = "English (US)",
volume = "305",
pages = "323--330",
journal = "Journal of Pharmacology and Experimental Therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "1",

}

TY - JOUR

T1 - Antidepressant-like effects of κ-opioid receptor antagonists in the forced swim test in rats

AU - Mague, Stephen D.

AU - Pliakas, Andrea M.

AU - Todtenkopf, Mark S.

AU - Tomasiewicz, Hilarie C.

AU - Zhang, Yan

AU - Stevens, William C.

AU - Jones, Robert M.

AU - Portoghese, Philip S.

AU - Carlezon, William A.

PY - 2003/4/1

Y1 - 2003/4/1

N2 - We showed previously that cAMP response element-binding protein (CREB) within the nucleus accumbens (NAc) of rats regulates immobility in the forced swim test (FST), an assay used to study depression. Because CREB regulates expression of dynorphin (which acts at κ-opioid receptors) in NAc neurons, these findings raised the possibility that κ-receptors mediate immobility behaviors in the FST. Here, we report that i.c.v. administration of the κ-antagonist nor-binaltorphimine dose dependently decreased immobility in the FST, suggesting that it has antidepressant-like effects. Implicating a specific effect at κ-receptors, similar antidepressant-like effects were seen after treatment with either of two novel, structurally dissimilar κ-antagonists: 5′-guanidinonaltrindole, which was effective after i.c.v. but not systemic treatment, and 5′-acetamidinoethylnaltrindole (ANTI), which was potent and effective after systemic treatment. The behavioral effects of the κ-antagonists resembled those of tricyclic antidepressants (desipramine) and selective serotonin reuptake inhibitors (fluoxetine and citalopram). Conversely, systemic administration of the κ-agonist [5α,7α,8β]-N-methyl-N-[7-[1-pyrrolidinyl] -1-oxaspiro[4.5]dec8-yl]-benzenacetamide (U-69593) dose dependently increased immobility in the FST, consistent with prodepressant-like effects. The effects of the κ-ligands in the FST were not correlated with nonspecific effects on locomotor activity. Furthermore, the most potent and effective κ-antagonist (ANTI) did not affect the rewarding impact of lateral hypothalamic brain stimulation at a dose with strong antidepressant-like effects. These findings are consistent with the hypothesis that CREB-mediated induction of dynorphin in the NAc "triggers" immobility behavior in the FST. Furthermore, they raise the possibility that κ-antagonists may have efficacy as antidepressants, but lack stimulant or rewardrelated effects.

AB - We showed previously that cAMP response element-binding protein (CREB) within the nucleus accumbens (NAc) of rats regulates immobility in the forced swim test (FST), an assay used to study depression. Because CREB regulates expression of dynorphin (which acts at κ-opioid receptors) in NAc neurons, these findings raised the possibility that κ-receptors mediate immobility behaviors in the FST. Here, we report that i.c.v. administration of the κ-antagonist nor-binaltorphimine dose dependently decreased immobility in the FST, suggesting that it has antidepressant-like effects. Implicating a specific effect at κ-receptors, similar antidepressant-like effects were seen after treatment with either of two novel, structurally dissimilar κ-antagonists: 5′-guanidinonaltrindole, which was effective after i.c.v. but not systemic treatment, and 5′-acetamidinoethylnaltrindole (ANTI), which was potent and effective after systemic treatment. The behavioral effects of the κ-antagonists resembled those of tricyclic antidepressants (desipramine) and selective serotonin reuptake inhibitors (fluoxetine and citalopram). Conversely, systemic administration of the κ-agonist [5α,7α,8β]-N-methyl-N-[7-[1-pyrrolidinyl] -1-oxaspiro[4.5]dec8-yl]-benzenacetamide (U-69593) dose dependently increased immobility in the FST, consistent with prodepressant-like effects. The effects of the κ-ligands in the FST were not correlated with nonspecific effects on locomotor activity. Furthermore, the most potent and effective κ-antagonist (ANTI) did not affect the rewarding impact of lateral hypothalamic brain stimulation at a dose with strong antidepressant-like effects. These findings are consistent with the hypothesis that CREB-mediated induction of dynorphin in the NAc "triggers" immobility behavior in the FST. Furthermore, they raise the possibility that κ-antagonists may have efficacy as antidepressants, but lack stimulant or rewardrelated effects.

UR - http://www.scopus.com/inward/record.url?scp=0037381053&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037381053&partnerID=8YFLogxK

U2 - 10.1124/jpet.102.046433

DO - 10.1124/jpet.102.046433

M3 - Article

VL - 305

SP - 323

EP - 330

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

SN - 0022-3565

IS - 1

ER -